Overview KVUS at Neoadjuvant CTx of Breast Cancer Status: Unknown status Trial end date: 2019-12-12 Target enrollment: Participant gender: Summary Effect of the contrast-enhanced diagnostic ultrasound during neoadjuvant chemotherapy of breast cancer on the achieved tumor size reduction and tolerability of chemotherapy Phase: Phase 3 Details Lead Sponsor: RWTH Aachen UniversityCollaborator: Univ.-Prof. Dr. med. F. Kiessling